Glucagon-like peptide-1 (GLP-1) is a glucoregulatory hormone synthetized in the intestines and the brain, involved in the maintenance of energy homeostasis mainly by stimulating insulin secretion and regulation of appetite
Demographic data, comorbidities, pathology reports, tumor characteristics, presenting symptoms, lesion characteristics, surgical management and outcomes, and duration of follow-up were abstracted from the electronic health records
Summary: Common weight-loss and diabetes medications, known as GLP-1 receptor agonists (including semaglutide and liraglutide), show comprehensive evidence of tackling the underlying causes of Alzheimers disease
Skip the next scheduled dose and resume at your standard dose 24 hours later
In a broader sense, it is always a good idea to report medications to all of your physicianseven if they seem unrelated